Around that time Jean-Claude Tardif, a cardiologist at the Montreal Heart Institute, was doing his own work with probucol.

FORBES: Magazine Article

The trial was to determine whether the drug kept the arteries from reclosing as much as those treated with probucol.

FORBES: Health

But Tardif also knew probucol wasn't viable.

FORBES: Health